Literature DB >> 20804877

Adiponectin and bone mass density: The InCHIANTI study.

Nicola Napoli1, Claudio Pedone, Paolo Pozzilli, Fulvio Lauretani, Luigi Ferrucci, Raffaele Antonelli Incalzi.   

Abstract

INTRODUCTION: Adiponectin serum concentration has been reported to be inversely correlated with bone mineral density (BMD) in humans. The data on this issue, however, are biased by small study sample size and lack of controlling for body composition.
METHODS: We used data from the third follow-up of the InCHIANTI study, which included measurements of BMD using quantitative CT of the tibia and of body composition using bioimpedenziometry. Serum adiponectin was measured using radioimmunoassay. We excluded participants with diabetes, hyperthyroidism, using hormone replacement or corticosteroid therapy. We evaluated the correlation of adiponectin with total, trabecular, and cortical BMD using Pearson's coefficient, and linear regression models to estimate the association between adiponectin and BMD controlling for potential confounders (age, body mass index, alcohol intake, fat mass, smoking).
RESULTS: Our sample was made up of 320 men (mean age: 67 years, SD: 15.8, range: 29-97 years) and 271 postmenopausal women (mean age: 76 years, SD: 8.2, range: 42-97 years). In men, serum adiponectin was not independently associated with BMD. In women, after correction for potential confounders, adiponectin was associated with total (β=-0.626, P<0.001), trabecular (β=-0.696, P<0.001), and cortical (β=-1.076, P=0.001) BMD.
CONCLUSION: Our results show that adiponectin is inversely associated with bone mass in women. Further studies are needed to confirm these findings prospectively and then to clarify the explanatory mechanisms.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20804877      PMCID: PMC4623316          DOI: 10.1016/j.bone.2010.08.010

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  48 in total

1.  Leptin regulates bone formation via the sympathetic nervous system.

Authors:  Shu Takeda; Florent Elefteriou; Regis Levasseur; Xiuyun Liu; Liping Zhao; Keith L Parker; Dawna Armstrong; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

2.  The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae.

Authors:  S D Rockoff; E Sweet; J Bleustein
Journal:  Calcif Tissue Res       Date:  1969

3.  Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans.

Authors:  Reiko Nakashima; Nozomu Kamei; Kiminori Yamane; Shuhei Nakanishi; Ayumu Nakashima; Nobuoki Kohno
Journal:  J Clin Endocrinol Metab       Date:  2006-08-01       Impact factor: 5.958

4.  Evaluation of cortical bone by computed tomography.

Authors:  T N Hangartner; V Gilsanz
Journal:  J Bone Miner Res       Date:  1996-10       Impact factor: 6.741

5.  Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways.

Authors:  Yusuke Shinoda; Masayuki Yamaguchi; Naoshi Ogata; Toru Akune; Naoto Kubota; Toshimasa Yamauchi; Yasuo Terauchi; Takashi Kadowaki; Yasuhiro Takeuchi; Seiji Fukumoto; Toshiyuki Ikeda; Kazuto Hoshi; Ung-il Chung; Kozo Nakamura; Hiroshi Kawaguchi
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

6.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.

Authors:  Kazuya Oshima; Akihide Nampei; Morihiro Matsuda; Masanori Iwaki; Atsunori Fukuhara; Jun Hashimoto; Hideki Yoshikawa; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

Review 7.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

8.  High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures.

Authors:  Laurence Vico; Mohamed Zouch; Adel Amirouche; Delphine Frère; Norbert Laroche; Bruno Koller; Andres Laib; Thierry Thomas; Christian Alexandre
Journal:  J Bone Miner Res       Date:  2008-11       Impact factor: 6.741

9.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

10.  Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification.

Authors:  Xiang-Hang Luo; Li-Ling Zhao; Ling-Qing Yuan; Min Wang; Hui Xie; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

View more
  28 in total

1.  Hip geometry in diabetic women: implications for fracture risk.

Authors:  Rajesh Garg; Zhao Chen; Thomas Beck; Jane A Cauley; Guanglin Wu; Dorothy Nelson; Beth Lewis; Andrea LaCroix; Meryl S LeBoff
Journal:  Metabolism       Date:  2012-06-20       Impact factor: 8.694

2.  Relationship between bone cross-sectional area and indices of peripheral artery disease.

Authors:  Claudio Pedone; Simone Scarlata; Nicola Napoli; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Raffaele Antonelli Incalzi
Journal:  Calcif Tissue Int       Date:  2013-09-01       Impact factor: 4.333

3.  Association between high-molecular-weight adiponectin and bone mineral density in hemodialysis patients.

Authors:  Nobuyuki Amemiya; Shigeru Otsubo; Yuko Iwasa; Takako Onuki; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-11-14       Impact factor: 2.801

Review 4.  Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition.

Authors:  S Epstein; G Defeudis; S Manfrini; N Napoli; P Pozzilli
Journal:  Osteoporos Int       Date:  2016-03-15       Impact factor: 4.507

5.  Bone health as a function of adipokines and vitamin D pattern in elderly patients.

Authors:  Claudio Pedone; Nicola Napoli; Paolo Pozzilli; Fulvio Lauretani; Stefania Bandinelli; Luigi Ferrucci; Francesca Flavia Rossi; Raffaele Antonelli-Incalzi
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

Review 6.  Bone Cell Bioenergetics and Skeletal Energy Homeostasis.

Authors:  Ryan C Riddle; Thomas L Clemens
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

7.  The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women.

Authors:  N Tanna; K Patel; A E Moore; D Dulnoan; S Edwards; G Hampson
Journal:  J Endocrinol Invest       Date:  2017-06-23       Impact factor: 4.256

Review 8.  Obesity and bone.

Authors:  Juliet Compston
Journal:  Curr Osteoporos Rep       Date:  2013-03       Impact factor: 5.096

9.  Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

Authors:  Juliet E Compston; Julie Flahive; David W Hosmer; Nelson B Watts; Ethel S Siris; Stuart Silverman; Kenneth G Saag; Christian Roux; Maurizio Rossini; Johannes Pfeilschifter; Jeri W Nieves; J Coen Netelenbos; Lyn March; Andrea Z LaCroix; Frederick H Hooven; Susan L Greenspan; Stephen H Gehlbach; Adolfo Díez-Pérez; Cyrus Cooper; Roland D Chapurlat; Steven Boonen; Frederick A Anderson; Silvano Adami; Jonathan D Adachi
Journal:  J Bone Miner Res       Date:  2014-02       Impact factor: 6.741

10.  Associations among endocrine, inflammatory, and bone markers, body composition and weight loss induced bone loss.

Authors:  Marie A Labouesse; Erik R Gertz; Brian D Piccolo; Elaine C Souza; Gertrud U Schuster; Megan G Witbracht; Leslie R Woodhouse; Sean H Adams; Nancy L Keim; Marta D Van Loan
Journal:  Bone       Date:  2014-04-04       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.